{"schema_version":"secwatch.filing_event.v1","accession":"0001516551-23-000034","form_type":"8-K/A","ticker":"SKYE","cik":"0001516551","company_name":"Skye Bioscience, Inc.","filed_at":"2023-03-27T23:59:59+00:00","discovered_at":"2026-05-14T18:03:45.349325+00:00","generated_at":"2026-06-17T14:47:33.755354+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"Skye Bioscience appoints Director Deborah Charych to Nominating and Corporate Governance Committee","bullets":["On March 21, 2023, Board appointed Dr. Deborah Charych to the Nominating and Corporate Governance Committee, effective immediately.","Amendment to Feb 16, 2023 8-K that reported Dr. Charych's appointment as director.","No other changes to committee assignments or board composition."],"urls":{"canonical":"https://secwatch.observer/filing/0001516551-23-000034","json":"https://secwatch.observer/filing/0001516551-23-000034.json","markdown":"https://secwatch.observer/filing/0001516551-23-000034.md","text":"https://secwatch.observer/filing/0001516551-23-000034.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1516551/000151655123000034/0001516551-23-000034-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1516551/000151655123000034/skye-20230214.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-17T14:47:33.755354+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}